Important Information Regarding Rhopressa

Posted in Latest News on June 26, 2018.

During the June 22, 2018 Board of Optometry meeting, the board approved for addition to Rule 64B13-18.002 Formulary of Topical Ocular Pharmaceutical Agents, Rhopressa (netarsudil ophthalmic solution) 0.02%.

Important note, Rhopressa, at this time, cannot be prescribed by certified Optometrists in Florida until the rule has been approved. Once the rule has gone through the approval process, notice will be provided.



More Latest News

Nonopioid Alternatives Pamphlet
July 2, 2019

Click here to access the pamphlet for “Information on Nonopioid Alternatives for the Treatment of Pain” Continue reading


Telehealth
July 1, 2019

Click here for information on the new law that sets standards of practice and authorizes out-of-state health care practitioners to perform telehealth services for patients in Florida. Continue reading